Dr. Jill Johnsen receives Octapharma award for study of von Willebrand Factor in Pregnancy

April 5th, 2019

Emily Herrera, Ph.D.

Dr. Jill has been awarded funds by Octapharma to study postpartum bleeding in women with von Willebrand Disease when VWF levels are at least 100% during delivery and the immediate postpartum period.

We're using cookies to deliver you the best user experience. Learn More